Category: Healthcare economics

Over 80% of Americans are worried about rising prescription drug costs. GoodRx has emerged as a popular solution for consumers seeking lower medication prices, but many wonder: **How do pharmacies make money with GoodRx**? This article delves into the complex financial relationship between pharmacies, GoodRx, and the broader pharmaceutical ecosystem.

With some reports indicating an annual cost upwards of $73,000, Canakinumab (sold under the brand name Ilaris) is a high-priced biologic medication. Understanding **what is the price of Canakinumab 150 mg** requires looking beyond the sticker price to consider insurance coverage, patient assistance, and the specific medical indication.

According to a BMJ Medicine study, some of the most expensive new antibiotics show ambiguous evidence of added benefit yet carry significant costs. Determining what is the most expensive antibiotic can be complex, as costs vary dramatically based on location, treatment course length, and the specific pathogen being targeted. Several factors contribute to the high price tag of these powerful, and often last-resort, medications, including the immense research and development costs required to combat rising antimicrobial resistance.

Following its FDA approval in March 2024, the manufacturer Merck set the list price for a single vial of sotatercept (brand name Winrevair) at $14,000. This article provides an in-depth look at the cost implications of this groundbreaking pulmonary arterial hypertension (PAH) therapy and answers the critical question: how much will sotatercept cost?